A NEW study has developed a machine learning (ML) model capable of predicting lung perfusion in pulmonary embolism (PE) ...
The PEERLESS trial demonstrated that large-bore mechanical thrombectomy was more effective than catheter-directed ...
Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary ...
Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.
Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).
Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...
Health workers missed opportunities to save a young woman with autism who died in King's Lynn at the age of 18.
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback